AI assistant
Adicet Bio, Inc. — Director's Dealing 2022
Feb 18, 2022
34412_dirs_2022-02-17_dc42388a-6f7e-49df-b19e-7dace048f15d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2022-02-16
Reporting Person: Jakobovits Aya (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-02-16 | Common Stock | S | 2000 | $14.8319 | Disposed | 358343 | Indirect |
| 2022-02-16 | Common Stock | S | 2000 | $14.8319 | Disposed | 358345 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 138076 | Indirect |
Footnotes
F1: These sales were effected pursuant to Rule 10b5-1 trading plans previously adopted by the Reporting Person.
F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.52 to $15.13. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F3: Shares held in a trust of which Dr. Jakobovits' spouse is the trustee and Dr. Jakobovits' daughter is the beneficiary.
F4: Shares held in a trust of which Dr. Jakobovits' spouse is the trustee and Dr. Jakobovits' son is the beneficiary.
F5: Shares held in a revocable trust of which Dr. Jakobovits and her spouse are co-trustees.